These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30004658)

  • 21. Calling for rapid development of a safe and effective MERS vaccine.
    Hotez PJ; Bottazzi ME; Tseng CT; Zhan B; Lustigman S; Du L; Jiang S
    Microbes Infect; 2014 Jul; 16(7):529-31. PubMed ID: 24931059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MERS vaccine is technically feasible, but is it commerically feasible?
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1429-30. PubMed ID: 25396231
    [No Abstract]   [Full Text] [Related]  

  • 23. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
    Schindewolf C; Menachery VD
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus.
    Crameri G; Durr PA; Klein R; Foord A; Yu M; Riddell S; Haining J; Johnson D; Hemida MG; Barr J; Peiris M; Middleton D; Wang LF
    Emerg Infect Dis; 2016 Jun; 22(6):1071-4. PubMed ID: 27070733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Middle East respiratory syndrome vaccines.
    Perlman S; Vijay R
    Int J Infect Dis; 2016 Jun; 47():23-8. PubMed ID: 27062985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
    Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
    Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
    Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
    Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
    [No Abstract]   [Full Text] [Related]  

  • 28. Current advancements and potential strategies in the development of MERS-CoV vaccines.
    Zhang N; Jiang S; Du L
    Expert Rev Vaccines; 2014 Jun; 13(6):761-74. PubMed ID: 24766432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MERS-CoV vaccine candidates in development: The current landscape.
    Modjarrad K
    Vaccine; 2016 Jun; 34(26):2982-2987. PubMed ID: 27083424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
    PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.
    Wang C; Zheng X; Gai W; Zhao Y; Wang H; Wang H; Feng N; Chi H; Qiu B; Li N; Wang T; Gao Y; Yang S; Xia X
    Oncotarget; 2017 Feb; 8(8):12686-12694. PubMed ID: 27050368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing the MERS coronavirus threat.
    Haagmans BL; Osterhaus AD
    Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.
    Haagmans BL; van den Brand JM; Raj VS; Volz A; Wohlsein P; Smits SL; Schipper D; Bestebroer TM; Okba N; Fux R; Bensaid A; Solanes Foz D; Kuiken T; Baumgärtner W; Segalés J; Sutter G; Osterhaus AD
    Science; 2016 Jan; 351(6268):77-81. PubMed ID: 26678878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.
    Park WB; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Man Poon LL; Peiris M; Oh MD
    Emerg Infect Dis; 2015 Dec; 21(12):2186-9. PubMed ID: 26583829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).
    Lu L; Xia S; Ying T; Jiang S
    Emerg Microbes Infect; 2015 Jun; 4(6):e37. PubMed ID: 26954884
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi.
    Hunter JC; Nguyen D; Aden B; Al Bandar Z; Al Dhaheri W; Abu Elkheir K; Khudair A; Al Mulla M; El Saleh F; Imambaccus H; Al Kaabi N; Sheikh FA; Sasse J; Turner A; Abdel Wareth L; Weber S; Al Ameri A; Abu Amer W; Alami NN; Bunga S; Haynes LM; Hall AJ; Kallen AJ; Kuhar D; Pham H; Pringle K; Tong S; Whitaker BL; Gerber SI; Al Hosani FI
    Emerg Infect Dis; 2016 Apr; 22(4):647-56. PubMed ID: 26981708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First clinical trial of a MERS coronavirus DNA vaccine.
    Yoon IK; Kim JH
    Lancet Infect Dis; 2019 Sep; 19(9):924-925. PubMed ID: 31351923
    [No Abstract]   [Full Text] [Related]  

  • 40. Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.
    Aly M; Elrobh M; Alzayer M; Aljuhani S; Balkhy H
    PLoS One; 2017; 12(10):e0183850. PubMed ID: 29028812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.